Sapiens Neuro

Munchen, Germany Founded: 2011 • Age: 15 yrs Acquired By Medtronic
Developer of brain stimulation device to treat neurodegenerative disorders
Request Access

About Sapiens Neuro

Sapiens Neuro is a company based in Munchen (Germany) founded in 2011 was acquired by Medtronic in August 2014.. Sapiens Neuro has raised $55.91 million across 4 funding rounds from investors including Medtronic, Edmond de Rothschild and Life Sciences Partners. Sapiens Neuro operates in a competitive market with competitors including PhotoPharmics, Cala Health, Civitas Therapeutics, Charco Neurotech and Aleva Neuro, among others.

  • Headquarter Munchen, Germany
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Health Technology & Digital Health
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $55.91 M (USD)

    in 4 rounds

  • Latest Funding Round
    $23 M (USD), Series C

    Nov 28, 2013

  • Investors
    Medtronic

    & 5 more

  • Employee Count
    Employee Count
  • Acquired by
    Medtronic

    (Aug 26, 2014)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Sapiens Neuro

Sapiens Neuro has successfully raised a total of $55.91M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $23 million completed in November 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Series C — $23.0M
  • First Round

    (01 Jun 2011)

  • Investors Count 5
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2013 Amount Series C - Sapiens Neuro Valuation

investors

Feb, 2013 Amount Series B - Sapiens Neuro Valuation Inkef
Nov, 2011 Amount Series B - Sapiens Neuro Valuation Wellcome Trust
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Sapiens Neuro

Sapiens Neuro has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Medtronic, Edmond de Rothschild and Life Sciences Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
AI, deeptech, and healthcare tech companies are funded by Inkef.
Founded Year Domain Location
Investments are made in early-stage healthcare startups.
Founded Year Domain Location
Private equity investments in life sciences businesses are managed.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Sapiens Neuro

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Sapiens Neuro

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Sapiens Neuro Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Sapiens Neuro

Sapiens Neuro operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PhotoPharmics, Cala Health, Civitas Therapeutics, Charco Neurotech and Aleva Neuro, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Non-invasive phototherapy for Parkinson's disease is developed.
domain founded_year HQ Location
Wearable neuromodulation devices for essential tremor relief are developed.
domain founded_year HQ Location
Inhaled pulmonary therapies for Parkinson's motor fluctuations are developed.
domain founded_year HQ Location
Non-invasive wearable devices for Parkinson's management are developed.
domain founded_year HQ Location
Implantable deep brain stimulation systems are developed for neurological diseases.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Sapiens Neuro

Frequently Asked Questions about Sapiens Neuro

When was Sapiens Neuro founded?

Sapiens Neuro was founded in 2011.

Where is Sapiens Neuro located?

Sapiens Neuro is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.

Is Sapiens Neuro a funded company?

Sapiens Neuro is a funded company, having raised a total of $55.91M across 4 funding rounds to date. The company's 1st funding round was a Series B of $10M, raised on Jun 01, 2011.

What does Sapiens Neuro do?

Developer of brain stimulation device to treat neurodegenerative disorders. The company develops a Deep Brain Stimulating (DBS) therapy device that comprises image-guided programming technology for the treatment of Parkinsons disease.

Who are the top competitors of Sapiens Neuro?

Sapiens Neuro's top competitors include PhotoPharmics, Cala Health and Aleva Neuro.

Who are Sapiens Neuro's investors?

Sapiens Neuro has 6 investors. Key investors include Medtronic, Edmond de Rothschild, Life Sciences Partners, Inkef, and Wellcome.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available